Classification
Product TypeIngredient
Product FormBulk ingredient (typically powder or viscous liquid)
Industry PositionNutraceutical / dietary supplement ingredient
Market
In Mexico, panthenol (commonly marketed as dexpanthenol / D-panthenol) is primarily relevant as an input for regulated finished products, with the supplements category overseen by COFEPRIS. Finished dietary supplements are regulated as “suplementos alimenticios” and cannot be marketed with therapeutic claims, and COFEPRIS requires specific labeling and advertising limitations. Imports of supplements require a Permiso Sanitario Previo de Importación (PSPI), where COFEPRIS reviews labeling and ingredients, making compliance readiness a core market access determinant. Public sources used in this record do not provide panthenol-specific Mexico production or market-size statistics, so quantitative market sizing is treated as a data gap.
Market RoleImport-dependent ingredient and formulation market (regulatory-driven access)
Domestic RoleB2B input for finished supplements and related regulated consumer goods; domestic activity is primarily formulation/packaging rather than upstream manufacture (not quantified in public sources here)
Market GrowthNot Mentioned
Risks
Regulatory Compliance HighMisclassification and claim-positioning risk can block market entry: products positioned with therapeutic/preventive claims may be treated as insumos para la salud rather than suplementos alimenticios, changing the authorization pathway; additionally, COFEPRIS requires a PSPI for importing supplements and reviews ingredients and labeling as part of the permit decision.Obtain a COFEPRIS classification consult early; prepare a PSPI-ready dossier (ingredients rationale, labels in Spanish for Mexico, and lot-specific CoA) aligned to the intended category and avoid therapeutic claims on labels/marketing.
Labeling And Claims MediumLabeling non-compliance and implied-disease claims can trigger detention, market withdrawal, or corrective actions; COFEPRIS actively enforces NOM-051-related labeling rules for prepackaged products and supplements guidance restricts claims that suggest prevention/treatment of disease.Validate labels against COFEPRIS NOM-051 implementation materials and supplements guidance; ensure required legends (e.g., non-medicine positioning where applicable) and avoid prohibited health claims.
Documentation Gap MediumIncomplete or inconsistent supporting documents (e.g., missing lot-specific CoA or mismatch between label, invoice, and supporting certificates) can delay PSPI approval and border clearance for regulated products.Use a pre-shipment document checklist aligned to COFEPRIS PSPI modality; harmonize product name, batch/lot, composition, and label text across all documents.
Quality Assurance MediumIf panthenol is used in ingestible supplements, quality and contaminant control expectations (identity, purity, and appropriate microbiological/physicochemical results) can be a gating issue during importer QA release and COFEPRIS-facing review.Source from qualified suppliers with consistent CoA packages and defined specifications; implement incoming testing (identity/purity and relevant contaminants) matched to the intended finished-product category.
Labor & Social- No widely documented Mexico-specific labor controversy uniquely associated with panthenol was identified in the public sources used for this record; main social risk is compliance-driven (misleading therapeutic claims) rather than a known forced-labor or deforestation linkage.
FAQ
Do dietary supplements require a sanitary import permit in Mexico?Yes. COFEPRIS states that dietary supplements (“suplementos alimenticios”) require a Permiso Sanitario Previo de Importación (PSPI), and COFEPRIS reviews the product’s labeling and ingredients as part of granting the permit.
Can a panthenol-containing supplement be marketed in Mexico as treating or preventing a disease?No. COFEPRIS guidance for dietary supplements emphasizes that supplements are not intended to treat, cure, prevent, or relieve disease symptoms, and marketing/labeling should not suggest therapeutic properties; products presented with therapeutic claims may fall under different health-supply rules.
What kinds of documents does COFEPRIS commonly reference for importing supplements?COFEPRIS describes PSPI import modalities where documentation can include labels (including the Spanish label used for commercialization in Mexico) and product/lot documentation such as certificates of analysis and certificates such as free sale or health certificates depending on the modality.